Sign Up to like & get
recommendations!
0
Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-3255
Abstract: Immune checkpoint inhibitors (ICI) may overcome cancer cells' ability to evade the immune system and proliferate. The long-term benefit of ICI in the metastatic setting led to evaluate neoadjuvant ICI approaches in several tumor types…
read more here.
Keywords:
challenges neoadjuvant;
panorama challenges;
neoadjuvant ici;
neoadjuvant cancer ... See more keywords